Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. The company is headquartered in Rahway, New Jersey and currently employs 75,000 full-time employees. Its Pharmaceutical segment includes human health pharmaceutical and vaccine products. The firm sells its human health pharmaceutical products primarily to drug wholesalers and retailers, hospitals, government agencies and managed health care providers. The company sells these human health vaccines primarily to physicians, wholesalers, distributors and government entities. Its Animal Health segment discovers, develops, manufactures and markets a range of veterinary pharmaceutical and vaccine products, as well as health management solutions and services, for the prevention, treatment and control of disease in all livestock and companion animal species. Its products include KEYTRUDA (pembrolizumab) injection, for intravenous use; WELIREG (belzutifan) tablets, for oral use; Ohtuvayre (ensifentrine) and others.
Merck & Co Inc hisse başına yıllık % {var1} temettüye sahiptir ve % {var2} oranında bir getiri sunmaktadır. Temettü üç ayda bir ödenmektedir ve son temettü hariç tarihi Dec 15, 2025 tarihindedir.
Dividend Yield
Yıllık Dividende
Özsermaye Tarihi
3.7866%
$3.40
Dec 15, 2025
Ödeme Sıklığı
Ödeme Oranı
Üç ayda bir
42.60%
Dividend History
Özsermaye Tarihi
Nakit Tutarı
Kayıt Tarihi
Ödeme Tarihi
Dec 15, 2025
$0.85
Dec 15, 2025
Jan 8, 2026
Sep 15, 2025
$0.81
Sep 15, 2025
Oct 7, 2025
Jun 16, 2025
$0.81
Jun 16, 2025
Jul 8, 2025
Mar 17, 2025
$0.81
Mar 17, 2025
Apr 7, 2025
Dec 16, 2024
$0.81
Dec 16, 2024
Jan 8, 2025
Sep 16, 2024
$0.77
Sep 16, 2024
Oct 7, 2024
Dividend Grafikleri
MRK Kâr Payları
MRK Dividend Growth (Yıllık Üstünlük)
Follow-Up Questions
Merck & Co Inc'in şu anki temettü ödemesi ve yıllık temettüsü nedir?